Last reviewed · How we verify

NCT05242939

Active and Passive Distraction Techniques

Completed NA Last updated 20 July 2022
What this trial tests

NA trial testing Video game in Child, Only in 99 participants. Completed in 30 April 2022.

Timeline
30 December 2021
Primary endpoint
19 February 2022
30 April 2022

Quick facts

Lead sponsorAkdeniz University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment99
Start date30 December 2021
Primary completion19 February 2022
Estimated completion30 April 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Akdeniz University

Who can join

Adults 4 to 7, any sex, with Child, Only or Inhalation Therapy; Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Treatment methods with nebulizers are used in the treatment of many diseases such as asthma, bronchitis, bronchiolitis and cystic fibrosis in children. Because inhalation therapy with a face mask is scary for children, it can be difficult to provide this therapy effectively and safely. Adaptation of the child and family is important for the success of inhalation therapy. Distraction techniques are among the most commonly used cognitive/behavioral methods. It determines the effect of "playing video games" and "watching cartoons" methods, which are active distraction methods during inhalation therapy, on the level of fear and anxiety.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Video game

Trials testing the same drug.

Other recruiting trials for Child, Only

Currently open trials in the same condition.

Other Akdeniz University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05242939.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing